⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,823.50
−0.19%
FTSE ADX
9,790.47
−0.40%
TASI
9,952.06
−1.69%
QE Index
8,658.85
+0.70%
S&P 500
7,712.57
+0.28%
Nasdaq 100
29,490.28
−0.13%
Nifty 50
22,704.40
−0.81%
Sensex
73,360.48
−0.67%
KSE-100
165,671.54
+0.31%
DFM:EMIRATESNBD
AED 31.60
+0.06%
ADX:IHC
AED 353.80
−0.79%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.54
−0.06%
NAS:NVDA
$216.47
−0.29%
NYSE:TSM
$425.08
+1.16%
NSE:RELIANCE
₹1,209.60
+0.63%
KAR:OGDC
Rs 300.48
+0.16%
Gold
$4,114.39
−0.27%
Brent
$110.16
+0.98%
BTC
$82,671.58
−0.33%
ETH
$2,438.72
−0.33%
DFM General
5,823.50
−0.19%
FTSE ADX
9,790.47
−0.40%
TASI
9,952.06
−1.69%
QE Index
8,658.85
+0.70%
S&P 500
7,712.57
+0.28%
Nasdaq 100
29,490.28
−0.13%
Nifty 50
22,704.40
−0.81%
Sensex
73,360.48
−0.67%
KSE-100
165,671.54
+0.31%
DFM:EMIRATESNBD
AED 31.60
+0.06%
ADX:IHC
AED 353.80
−0.79%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.54
−0.06%
NAS:NVDA
$216.47
−0.29%
NYSE:TSM
$425.08
+1.16%
NSE:RELIANCE
₹1,209.60
+0.63%
KAR:OGDC
Rs 300.48
+0.16%
Gold
$4,114.39
−0.27%
Brent
$110.16
+0.98%
BTC
$82,671.58
−0.33%
ETH
$2,438.72
−0.33%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Open
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› AARD
A
Aardvark Therapeutics Inc
NAS:AARD
Healthcare
NASDAQ:NBI
nasdaq_composite
$3.90
+4.28%
At close
At close · Wed 21 Oct · ≈
AED 14.32
· Market cap
$85.35M
· Next earnings
Thu 12 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
AARD news
Headlines tagged to this company
DO
Aardvark Therapeutics Price Target Cut to $4.00/Share From $6.00 by HC Wainwright & Co.
Dow Jones Newswires · 2 d ago
TR
HC Wainwright & Co. maintains Neutral rating on Aardvark Therapeutics, $4 price target
TradingView · 2 d ago
TR
David (Zhongwei) Zhang appointed to Aard board as Class II director
TradingView · 13 d ago
RE
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors
Reuters · 13 d ago
TR
Aardvark Therapeutics, Inc. (AARD) Adds David Zhang to Board
TradingView · 13 d ago
PR
AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, A TOP RANKED LAW FIRM, Encourages Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline
PR Newswire · 14 d ago
PR
AARD 6-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline
PR Newswire · 14 d ago
GL
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 19 d ago
PR
AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
PR Newswire · 20 d ago
PR
AARD 12-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline
PR Newswire · 20 d ago
GL
AARD Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Aardvark Therapeutics, Inc. Class Action Lawsuit
GlobeNewsWire · 63 d ago
BU
Securities Fraud Investigation Into Aardvark Therapeutics, Inc. (AARD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Business Wire · 63 d ago
NE
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit
Newsfile Corp · 63 d ago
PR
AARD Shareholder Alert: October 13, 2026 Lead Plaintiff Deadline in Aardvark Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky
PRNewsWire · 63 d ago
NE
ROSEN, A LEADING NATIONAL FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
Newsfile Corp · 63 d ago
GL
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
GlobeNewsWire · 64 d ago
GL
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD
GlobeNewsWire · 64 d ago
NE
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Newsfile Corp · 64 d ago
NE
AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
Newsfile Corp · 65 d ago
GL
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action
GlobeNewsWire · 65 d ago
More news →
Aardvark Therapeutics Inc · News · TradingHolo